NEW YORK, July 24 /PRNewswire/ --

- EU-5 mobile music retail revenues to exceed US$1.4 billion in 2012

Europe's mobile music scene is more advanced than that in the US. While the UK is the biggest individual mobile music market in the EU-5, the other countries -- France, Germany, Italy and Spain -- are reporting sharp growth as well. eMarketer predicts that mobile music retail revenues in the EU-5 will reach over US$1.4 billion by 2012, up from US$267 million in 2007. eMarketer expects ad-supported mobile music in the EU-5 to reach US$170 million in 2012, up from US$4.6 million in 2007.

To see chart, click here:

Mobile Music Spending in the EU-5, by Format, 2007-2012 (millions) http://totalaccess.emarketer.com/images/chart_gifs/095001-096000/095967.gif

RESTON, Virginia, July 24 /PRNewswire/ --

- As families hit the road this summer, more will be turning to the mobile device for turn-by-turn directions.

- Mobile map usage growing much faster than online map usage

LONDON, July 24 /PRNewswire/ --

Nearly half of lazy UK fellas believe they come up with their greatest ideas whilst resting on their mattress, whilst 1 in 10 think they find their most useful inspiration on the loo.

The poll also found Britons picked the internet (36%) as the greatest invention or discovery in the world, followed by antibiotics (27%) and computers (20%).

ALBUQUERQUE, New Mexico, July 24 /PRNewswire/ --

Emirates Airline began use of ULTRAMAIN maintenance and integrated logistics software on June 2, 2008. ULTRAMAIN is developed by Ultramain Systems, Inc., (USI) of Albuquerque, NM, USA.

REHOVOT, Israel and JERSEY CITY, New Jersey, July 24 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc. ("Parkway"), a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of Rosetta's ordinary shares. An additional $300,000 will be payable upon the achievement of certain milestones. The lab owned by Parkway is an CLIA-certified clinical reference laboratory with an expected $2.7M in revenues and break-even operating income in 2008.

LONDON, July 24 /PRNewswire/ --

- Output of New Molecular Entities Drops to Historic Low as Pharma Companies Face Increasing Competition from Generics Companies

The Scientific business of Thomson Reuters today announced the availability of the newly published CMR International 2008 Pharmaceutical R&D Factbook, an indispensable reference and business planning tool for decision makers in pharmaceutical R&D, corporate finance, business strategy, marketing planning and corporate communications. This year's Factbook offers a comprehensive and up-to-date overview of emerging trends in worldwide pharmaceutical R&D and has been considerably enhanced with data sourced from other Thomson Reuters businesses providing insight into areas such as generic drugs and patents.